121 related articles for article (PubMed ID: 29274910)
1. Disruption of liver development and coagulation pathway by ochratoxin A in embryonic zebrafish.
Wu TS; Lin YT; Huang YT; Cheng YC; Yu FY; Liu BH
Toxicol Appl Pharmacol; 2018 Feb; 340():1-8. PubMed ID: 29274910
[TBL] [Abstract][Full Text] [Related]
2. Aflatoxin B1 interferes with embryonic liver development: Involvement of p53 signaling and apoptosis in zebrafish.
Cheng YC; Wu TS; Huang YT; Chang Y; Yang JJ; Yu FY; Liu BH
Toxicology; 2021 Jun; 458():152844. PubMed ID: 34214637
[TBL] [Abstract][Full Text] [Related]
3. Teratogenicity of Ochratoxin A and the Degradation Product, Ochratoxin α, in the Zebrafish (Danio rerio) Embryo Model of Vertebrate Development.
Haq M; Gonzalez N; Mintz K; Jaja-Chimedza A; De Jesus CL; Lydon C; Welch A; Berry JP
Toxins (Basel); 2016 Feb; 8(2):40. PubMed ID: 26861395
[TBL] [Abstract][Full Text] [Related]
4. Ochratoxin a inhibits mouse embryonic development by activating a mitochondrion-dependent apoptotic signaling pathway.
Hsuuw YD; Chan WH; Yu JS
Int J Mol Sci; 2013 Jan; 14(1):935-53. PubMed ID: 23296271
[TBL] [Abstract][Full Text] [Related]
5. Effects of ochratoxin a on mouse oocyte maturation and fertilization, and apoptosis during fetal development.
Huang FJ; Chan WH
Environ Toxicol; 2016 Jun; 31(6):724-35. PubMed ID: 25504763
[TBL] [Abstract][Full Text] [Related]
6. Prevention of ochratoxin A-induced oxidative stress-mediated apoptotic processes and impairment of embryonic development in mouse blastocysts by liquiritigenin.
Huang CH; Wang FT; Chan WH
Environ Toxicol; 2019 May; 34(5):573-584. PubMed ID: 30698892
[TBL] [Abstract][Full Text] [Related]
7. Ochratoxin A triggered intracerebral hemorrhage in embryonic zebrafish: Involvement of microRNA-731 and prolactin receptor.
Wu TS; Lin YT; Huang YT; Yu FY; Liu BH
Chemosphere; 2020 Mar; 242():125143. PubMed ID: 31675585
[TBL] [Abstract][Full Text] [Related]
8. A toxicogenomics approach to identify new plausible epigenetic mechanisms of ochratoxin a carcinogenicity in rat.
Marin-Kuan M; Nestler S; Verguet C; Bezençon C; Piguet D; Mansourian R; Holzwarth J; Grigorov M; Delatour T; Mantle P; Cavin C; Schilter B
Toxicol Sci; 2006 Jan; 89(1):120-34. PubMed ID: 16251485
[TBL] [Abstract][Full Text] [Related]
9. Mycotoxin ochratoxin A disrupts renal development
Wu TS; Yang JJ; Wang YW; Yu FY; Liu BH
Toxicol Res (Camb); 2016 Mar; 5(2):519-529. PubMed ID: 30090366
[TBL] [Abstract][Full Text] [Related]
10. Immunotoxic effects of Ochratoxin A in Wistar rats after oral administration.
Alvarez L; Gil AG; Ezpeleta O; García-Jalón JA; López de Cerain A
Food Chem Toxicol; 2004 May; 42(5):825-34. PubMed ID: 15046829
[TBL] [Abstract][Full Text] [Related]
11. Ochratoxin A induces G(2) phase arrest in human gastric epithelium GES-1 cells in vitro.
Cui J; Xing L; Li Z; Wu S; Wang J; Liu J; Wang J; Yan X; Zhang X
Toxicol Lett; 2010 Mar; 193(2):152-8. PubMed ID: 20060447
[TBL] [Abstract][Full Text] [Related]
12. Ochratoxin A alters cell adhesion and gap junction intercellular communication in MDCK cells.
Mally A; Decker M; Bekteshi M; Dekant W
Toxicology; 2006 Jun; 223(1-2):15-25. PubMed ID: 16621214
[TBL] [Abstract][Full Text] [Related]
13. Ochratoxin A exposure decreased sperm motility via the AMPK and PTEN signaling pathways.
Zhang TY; Wu RY; Zhao Y; Xu CS; Zhang WD; Ge W; Liu J; Sun ZY; Zou SH; Shen W
Toxicol Appl Pharmacol; 2018 Feb; 340():49-57. PubMed ID: 29274354
[TBL] [Abstract][Full Text] [Related]
14. Hepatotoxic effect of ochratoxin A and citrinin, alone and in combination, and protective effect of vitamin E: In vitro study in HepG2 cell.
Gayathri L; Dhivya R; Dhanasekaran D; Periasamy VS; Alshatwi AA; Akbarsha MA
Food Chem Toxicol; 2015 Sep; 83():151-63. PubMed ID: 26111808
[TBL] [Abstract][Full Text] [Related]
15. Modulation of key regulators of mitosis linked to chromosomal instability is an early event in ochratoxin A carcinogenicity.
Adler M; Müller K; Rached E; Dekant W; Mally A
Carcinogenesis; 2009 Apr; 30(4):711-9. PubMed ID: 19237604
[TBL] [Abstract][Full Text] [Related]
16. Assessment and characterisation of yeast-based products intended to mitigate ochratoxin exposure using in vitro and in vivo models.
Pfohl-Leszkowicz A; Hadjeba-Medjdoub K; Ballet N; Schrickx J; Fink-Gremmels J
Food Addit Contam Part A Chem Anal Control Expo Risk Assess; 2015; 32(4):604-16. PubMed ID: 25296248
[TBL] [Abstract][Full Text] [Related]
17. Histopathologic changes in liver and renal tissues induced by Ochratoxin A and melatonin in rats.
Aydin G; Ozçelik N; Ciçek E; Soyöz M
Hum Exp Toxicol; 2003 Jul; 22(7):383-91. PubMed ID: 12929728
[TBL] [Abstract][Full Text] [Related]
18. Significance of apoptosis and its relationship to antioxidants after ochratoxin A administration in mice.
Atroshi F; Biese I; Saloniemi H; Ali-Vehmas T; Saari S; Rizzo A; Veijalainen P
J Pharm Pharm Sci; 2000; 3(3):281-91. PubMed ID: 11177646
[TBL] [Abstract][Full Text] [Related]
19. Functional, biochemical, and pathological effects of repeated oral administration of ochratoxin A to rats.
Mally A; Völkel W; Amberg A; Kurz M; Wanek P; Eder E; Hard G; Dekant W
Chem Res Toxicol; 2005 Aug; 18(8):1242-52. PubMed ID: 16097797
[TBL] [Abstract][Full Text] [Related]
20. Effect of ochratoxin A on redox-regulated transcription factors, antioxidant enzymes and glutathione-S-transferase in cultured kidney tubulus cells.
Boesch-Saadatmandi C; Loboda A; Jozkowicz A; Huebbe P; Blank R; Wolffram S; Dulak J; Rimbach G
Food Chem Toxicol; 2008 Aug; 46(8):2665-71. PubMed ID: 18547704
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
